Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial
Journal article published in 2019 by
Robert Haddad,
Fernando Concha‐Benavente,
George Blumenschein,
Jerome Fayette,
Joel Guigay,
A. Dimitrios Colevas,
Lisa Licitra 
,
Stefan Kasper,
Everett E. Vokes,
Francis Worden,
Nabil F. Saba ,
Makoto Tahara,
Vijayvel Jayaprakash,
Mark Lynch,
Li Li
and other authors.
,
Stefan Kasper,
Everett E. Vokes,
Francis Worden,
Nabil F. Saba ,
Makoto Tahara,
Vijayvel Jayaprakash,
Mark Lynch,
Li Li
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 